GEHC
GE HealthCare Technologies Inc.
64.20$
-0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.0% | 27.8% | 27.9% | 26.5% | 30.4% | 28.8% | 27.9% | 30.7% | 32.9% | 29.0% | 26.9% | 22.7% | |
| 7.5% | 7.7% | 8.0% | 6.3% | 10.5% | 8.7% | 7.4% | 10.6% | 11.1% | 12.2% | 6.2% | 5.7% | |
| 7.5% | 7.7% | 8.0% | 6.3% | 10.5% | 8.7% | 7.4% | 10.6% | 11.1% | 12.2% | 6.2% | 5.7% | |
| 12.8% | 13.3% | 12.7% | 13.0% | 12.6% | 13.2% | 13.0% | 12.6% | 13.0% | 10.7% | 12.8% | 10.4% | |
| 6.6% | 6.0% | 6.2% | 6.4% | 6.3% | 5.9% | 6.4% | 6.4% | 6.4% | 6.1% | 6.3% | 6.7% | |
| 39.9% | 39.9% | 40.1% | 41.2% | 38.8% | 39.7% | 39.8% | 37.8% | 37.2% | 36.5% | 40.6% | 40.5% | |
| 4.1% | 3.9% | 3.6% | 3.8% | 3.3% | 3.3% | 3.7% | 3.4% | 3.2% | 3.1% | 5.1% | 5.1% | |
| 77.4% | 77.5% | 76.4% | 74.9% | 74.9% | 73.8% | 72.0% | 72.0% | 71.7% | 71.3% | 70.6% | 70.5% | |
| 23.4% | 27.7% | 27.5% | 26.1% | 25.6% | 28.9% | 29.7% | 27.5% | 27.9% | 24.7% | 23.0% | 22.3% | |
| 0.0% | 3.4% | 3.5% | 3.5% | 3.3% | 4.9% | 6.3% | 6.4% | 5.9% | 1.4% | 0.4% | 0.0% | |
| 8.6% | 9.1% | 9.1% | 8.9% | 8.6% | 9.1% | 9.4% | 8.4% | 8.3% | 8.8% | 9.2% | 8.7% | |
| 31.7% | 26.0% | 25.6% | 25.8% | 27.5% | 22.5% | 20.1% | 23.3% | 22.9% | 25.7% | 27.3% | 27.1% | |
| 22.0% | 22.0% | 23.0% | 24.5% | 24.6% | 25.5% | 27.4% | 27.4% | 27.7% | 28.1% | 28.7% | 29.5% | |
| 2.9% | 4.1% | 5.2% | 6.6% | 7.6% | 9.9% | 11.3% | 12.1% | 13.0% | 14.3% | 15.2% | 16.6% | |
| 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.3% | 1.3% | 1.2% | 1.2% | 1.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.